RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Theralase = TLD-1433skys1 wrote: The science is just as valid as it was a year & 1/2 ago. It's just that since Shawn has shown up most has gone wrong.If it was up to me, I'd send him back from whence he came - Big Pharma. An accomplished CEO would straighten out this company in a few months.
Still, I believe the net result of the Ph 2 trial will be a CR % substantially above 60. That would put our ACT in the drivers seat of NMIBC treatment. That alone would put TLT's worth in the $ billions.
However, all that would become moot if 1433 becomes so valuable the a member of the big pharma community has to take us out to gain unlimited access to it, and I believe that to be a serious possibility.
Yep, go Roswell Park go!